Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Enzymes Stories

2012-08-23 23:50:10

Enzymes involved in breaking down fat can now be manipulated to work three times harder by turning on a molecular switch recently observed by chemists at the University of Copenhagen. Being able to control this chemical on/off button could have massive implications for curing diseases related to obesity including diabetes, cardio vascular disease, stroke and even skin problems like acne. But the implications may be wider. Possibly the most important discovery in enzymology The results...

Nonalcoholic Berry Wine Could Be Good For Diabetics
2012-08-21 10:31:02

Connie K. Ho for redOrbit.com — Your Universe Online “You are what you eat.” This quote has long highlighted the intersection between food and health for the body. Interestingly enough, a team of investigators from the University of Illinois (U of I) recently discovered compounds in Illinois blueberry and blackberry wines that stop enzymes that target carbohydrate absorption and assimilation. They believe that the tasty drink from berry wine could be a possible drug for...

Double Whammy From Brain Enzyme For Alzheimer's Disease
2012-08-20 08:22:40

Sanford-Burnham researchers discover that an enzyme known for generating toxic brain plaques in Alzheimer's disease also causes additional memory and cognitive deficits via a separate mechanism The underlying causes of Alzheimer's disease are not fully understood, but a good deal of evidence points to the accumulation of β-amyloid, a protein that's toxic to nerve cells. β-amyloid is formed by the activity of several enzymes, including one called BACE1. Most Alzheimer's disease...

2012-07-31 23:02:45

The CBS NY evening news recently featured the segment “Gray Hair is Less of a Worry for Some Women Lately Because of a Certain Pill”. Viewers witnessed a promising solution in the fight against gray hair with an all-natural supplement called Go Away Gray. Created by Rise-N-Shine, LLC, an all-natural supplement company from New Jersey, Go Away Gray is a 100% chemically free pill formulated with the enzyme catalase. Sparta, NJ (PRWEB) July 31, 2012 The CBS NY evening news recently...

2012-07-26 06:53:33

(Ivanhoe Newswire) — New research using mice and post-mortem samples of brains from patients with Alzheimer's disease found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The study reveals the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results could lead to the development of a drug treatment that targets this...

2012-07-25 13:00:38

A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer's disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug...

2012-07-25 06:37:29

(Ivanhoe Newswire) — New research using mice and post-mortem samples of brains from patients with Alzheimer's disease found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer's. The study reveals the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results could lead to the development of a drug treatment that targets this...

European Agency Recommends Gene Therapy Approval
2012-07-21 08:56:42

redOrbit Staff & Wire Reports - Your Universe Online A European Union agency for the evaluation of medicinal products is recommending the approval of a gene therapy treatment for a rare disease, which would be the first time a treatment of this kind has received the regulatory go-ahead for use in the West, according to various reports published Friday. A statement released by the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) officially...

2012-07-18 10:26:32

CAMBRIDGE, Mass., July 18, 2012 /PRNewswire/ -- Satori Pharmaceuticals, a company dedicated to developing life-changing therapeutics for Alzheimer's disease (AD), announced today that its lead compound, a gamma-secretase modulator (GSM), is efficacious in preclinical models following single or multi-day dosing. This oral presentation, as well as two poster presentations related to the characteristics of Satori's GSMs, was presented at the Alzheimer's Association International Conference...

2012-07-13 08:20:01

Tokyo, July 13, 2012 - (JCN Newswire) - Eisai Co., Ltd. announced today that first data from clinical studies with E2609, a BACE (beta-site amyloid precursor protein-cleaving enzyme) inhibitor discovered in-house, will be presented during oral sessions at the Alzheimer's Association International Conference (AAIC) 2012, taking place in Vancouver, Canada from July 14 to 19, 2012. E2609 is a BACE inhibitor currently being developed by Eisai as a next-generation oral Alzheimer's disease...